REVIEW OF RACIAL/ETHNIC DIFFERENCES IN PHARMACOKINETICS (PK), PHARMACOGENOMICS (PGX), SAFETY, AND EFFICACY OF NEW MOLECULAR ENTITIES APPROVED BETWEEN 2014 AND 2018.

被引：0
|
作者：
Ramamoorthy, A. [1 ]
Shah-Williams, E. [2 ]
机构：
[1] US FDA, Silver Spring, MD USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-102
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 4 条
  • [1] REVIEW OF RACIAL/ETHNIC DIFFERENCES IN PHARMACOKINETICS, PHARMACOGENOMICS, SAFETY, AND EFFICACY OF NEW MOLECULAR ENTITIES APPROVED BETWEEN 2014 AND 2018.
    Ramamoorthy, A.
    Shah-Williams, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S34 - S35
  • [2] Racial and Ethnic Differences in Drug Disposition and Response: Review of New Molecular Entities Approved Between 2014 and 2019
    Ramamoorthy, Anuradha
    Kim, Hannah H.
    Shah-Williams, Ebony
    Zhang, Lei
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (04): : 486 - 493
  • [3] Participation of racial/ethnic groups in clinical trials and race-related labeling: A review of new molecular entities approved 1995-1999
    Evelyn, B
    Toigo, T
    Banks, D
    Pohl, D
    Gray, K
    Robins, B
    Ernat, J
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2001, 93 (12) : 18S - 24S
  • [4] Postmarketing Safety-Related Regulatory Actions for New Therapeutic Biologics Approved in the United States 2002-2014: Similarities and Differences With New Molecular Entities
    Bulatao, Ilynn
    Pinnow, Ellen
    Day, Brendan
    Cherkaoui, Sanae
    Kalaria, Manish
    Brajovic, Sonja
    Dal Pan, Gerald
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (06) : 1243 - 1253
1